Business of Discovery Workshop

Nearly a quarter of ISSCR members say they want to start a business. We gathered the experts to answer threshold questions: where to start, or if you should start at all.

Tuesday, 23 June 2020

Join us for a three-part workshop on the business end of science. You'll meet with entrepreneurs, investors and business leaders as we explore the many paths from lab bench to market – where to start, or if you should start at all.

The full-day program will host panel discussions on building a business model and pitch, attracting investment, and real stories from the people doing it.

Investigational therapies, new tools, and promising technologies are quickly advancing in stem cell science and regenerative medicine. In step, more than 20 percent of ISSCR members surveyed indicate near-term plans to start a business or an interest in doing so. This workshop is designed for you.

Location: ISSCR 2020 VIRTUAL
Date: 23 June, 2020
Time: 10:30 — 17:30 EDT
Registration: Included with ISSCR 2020 VIRTUAL Annual Meeting registration.

Sponsor

Speakers + Topics

10:30-12:00 EDT | 23 June

[ Starting a business in stem cell research and regenerative medicine comes with its own set of threshold questions, challenges, and considerations. Explore the elements of a successful pitch and business plan unique to this space. ]

WORKSHOP OPENING REMARKS
[Program Committee + Session Chair]
Brock Reeve, MPhil, MBA
Executive Director
Harvard Stem Cell Institute

Armstrong_photo_approved_resize2

Andrea Armstrong, BA, MA
Chief Administrative Officer
Celsius Therapeutics

Isacson150x1502

Christina Isacson, PhD
Chief Business Officer
Magenta Therapeutics

Jay

James Bradner, MD
President
Novartis Institutes for BioMedical Research

13:00-14:45 EDT | 23 June

[ Where to go, who to talk to, and what they'll be looking for. Hear from a spectrum of investors from incubator to Wall Street. ]

Stephen Freedman

[Program Committee + Session Chair]
Stephen Freedman, PhD
Vice President for Corporate Liaison and Ventures
Gladstone Institutes

Crawford150x150

Douglas Crawford, PhD
Managing Director, Mission Bay Capital
General Manager, MBC Biolabs

DeWitt150x150

Ann DeWitt, PhD, MBA
General Partner, The Engine
Massachusetts Institute of Technology

Kumar2

Anjali Kumar, PhD
External Innovation Search and Evaluation, Johnson & Johnson Innovation
USA

Matt McMahon

Matt McMahon, PhD
Director, SEED
NIH, Office of Extramural Research

15:30-17:30 EDT | 23 June

[ Join entrepreneurs as they share their journeys from discovery to business. Hear their paths, approaches, and lessons learned. ]

Katherine High

[Program Committee + Session Chair]
Katherine A. High, MD
Co-Founder, Spark Therapeutics
Professor Emerita, Perelman School of Medicine at the University of Pennsylvania

Liu headshot - cropped_approved_resize